KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to 0.8.

  • Novavax's Asset Utilization Ratio rose 5858.71% to 0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8, marking a year-over-year increase of 5858.71%. This contributed to the annual value of 0.41 for FY2024, which is 1623.36% down from last year.
  • Latest data reveals that Novavax reported Asset Utilization Ratio of 0.8 as of Q3 2025, which was up 5858.71% from 0.77 recorded in Q2 2025.
  • Novavax's 5-year Asset Utilization Ratio high stood at 0.99 for Q2 2023, and its period low was 0.42 during Q4 2024.
  • For the 5-year period, Novavax's Asset Utilization Ratio averaged around 0.63, with its median value being 0.62 (2024).
  • As far as peak fluctuations go, Novavax's Asset Utilization Ratio soared by 50875.19% in 2021, and later tumbled by 3708.54% in 2024.
  • Quarter analysis of 5 years shows Novavax's Asset Utilization Ratio stood at 0.45 in 2021, then soared by 96.45% to 0.88 in 2022, then tumbled by 34.97% to 0.57 in 2023, then dropped by 26.8% to 0.42 in 2024, then skyrocketed by 90.74% to 0.8 in 2025.
  • Its last three reported values are 0.8 in Q3 2025, 0.77 for Q2 2025, and 0.88 during Q1 2025.